Institution · Tel Aviv University
Most cited papers from Tel Aviv University
Tel Aviv University
What are the most cited papers from Tel Aviv University?
The most cited paper from Tel Aviv University is "Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing" (Yoav Benjamini, Yosef Hochberg, 1995), with 112,351 citations. Next come "A global reference for human genetic variation" (20,444) and "Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance" (14,554).
Showing 50 of 58 papers. Every paper with more than 3,524 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing Yoav Benjamini, Yosef Hochberg · Journal of the Royal Statistical Society Series B (Statistical Methodology) | 1995 | 112,351 |
| 2 | A global reference for human genetic variation Corresponding authors et al. · Nature | 29 Sep 2015 | 20,444 |
| 3 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey et al. · Clinical Microbiology and Infection | 7 May 2011 | 14,554 |
| 4 | A Fast Iterative Shrinkage-Thresholding Algorithm for Linear Inverse Problems Amir Beck, Marc Teboulle · SIAM Journal on Imaging Sciences | 2009 | 12,347 |
| 5 | Observation of a new particle in the search for the Standard Model Higgs boson with the ATLAS detector at the LHC G. Aad et al. · Physics Letters B | 14 Aug 2012 | 10,856 |
| 6 | Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer Martin Reck, Delvys Rodríguez‐Abreu, Andrew George Robinson et al. · New England Journal of Medicine | 9 Oct 2016 | 10,303 |
| 7 | The random walk's guide to anomalous diffusion: a fractional dynamics approach Ralf Metzler, J. Klafter · Physics Reports | Dec 2000 | 9,129 |
| 8 | The Perseus computational platform for comprehensive analysis of (prote)omics data Stefka Tyanova, Tikira Temu, Pavel G. Sinitcyn et al. · Nature Methods | 27 Jun 2016 | 9,121 |
| 9 | Gaia Data Release 2 A. G. A. Brown et al. · Astronomy and Astrophysics | 24 Apr 2018 | 8,734 |
| 10 | Nanocarriers as an emerging platform for cancer therapy Dan Peer, Jeffrey M. Karp, Seungpyo Hong et al. · Nature Nanotechnology | Dec 2007 | 8,681 |
| 11 | An integrated map of genetic variation from 1,092 human genomes Gil A. McVean et al. · Nature | 31 Oct 2012 | 8,281 |
| 12 | Biological insights from 108 schizophrenia-associated genetic loci Stephan Ripke et al. · Nature | Jul 2014 | 8,181 |
| 13 | Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations Adam B. Jaffe, Manuel Trajtenberg, Rebecca M. Henderson · The Quarterly Journal of Economics | Aug 1993 | 7,941 |
| 14 | Novel Type of Phase Transition in a System of Self-Driven Particles Tamás Vicsek, András Czirók, Eshel Ben‐Jacob et al. · Physical Review Letters | 7 Aug 1995 | 7,543 |
| 15 | Review of Particle Physics Masaharu Tanabashi et al. · Physical review. D/Physical review. D. | 17 Aug 2018 | 7,268 |
| 16 | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) Spiros Miyakis, Michael D. Lockshin, Tatsuya Atsumi et al. · Journal of Thrombosis and Haemostasis | 13 Jan 2006 | 7,231 |
| 17 | The Gaia mission T. Prusti et al. · Astronomy and Astrophysics | 15 Sep 2016 | 7,118 |
| 18 | Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer Leena Gandhi et al. · New England Journal of Medicine | 16 Apr 2018 | 6,764 |
| 19 | DeepFace: Closing the Gap to Human-Level Performance in Face Verification Yaniv Taigman, Ming Juan Yang, Marc’Aurelio Ranzato et al. | Jun 2014 | 6,691 |
| 20 | Construal-level theory of psychological distance. Yaacov Trope, Nira Liberman · Psychological Review | 2010 | 6,585 |
| 21 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Theo Vos et al. · The Lancet | 7 Jun 2015 | 6,558 |
| 22 | Review of Particle Physics Particle Data Group et al. · Progress of Theoretical and Experimental Physics | Aug 2022 | 6,346 |
| 23 | Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Evelina Tacconelli et al. · The Lancet Infectious Diseases | 21 Dec 2017 | 6,293 |
| 24 | Dementia prevention, intervention, and care Gill Livingston et al. · The Lancet | 20 Jul 2017 | 6,271 |
| 25 | Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma Sattva Swarup Neelapu et al. · New England Journal of Medicine | 10 Dec 2017 | 6,098 |
| 26 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy | 2 Jan 2016 | 6,023 |
| 27 | Pembrolizumab versus Ipilimumab in Advanced Melanoma Caroline Robert et al. · New England Journal of Medicine | 19 Apr 2015 | 5,968 |
| 28 | The temporal logic of programs Amir Pnueli | Sep 1977 | 5,753 |
| 29 | The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines Riaz Agha et al. · International Journal of Surgery | 9 Nov 2020 | 5,605 |
| 30 | Conservation of Resources in the Organizational Context: The Reality of Resources and Their Consequences Stevan E. Hobfoll, Jonathon R. B. Halbesleben, Jean‐Pierre Neveu et al. · Annual Review of Organizational Psychology and Organizational Behavior | 10 Nov 2017 | 5,584 |
| 31 | Mate selection—A selection for a handicap Amotz Avishag Zahavi · Journal of Theoretical Biology | Sep 1975 | 5,378 |
| 32 | Asset pricing and the bid-ask spread Yakov Amihud, Haim Mendelson · Journal of Financial Economics | Dec 1986 | 5,367 |
| 33 | Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq Dan Dominissini, Sharon Moshitch-Moshkovitz, Schraga Schwartz et al. · Nature | 27 Apr 2012 | 5,167 |
| 34 | Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Martine J Piccart et al. · New England Journal of Medicine | 20 Oct 2005 | 5,138 |
| 35 | Diagnosis and management of dementia with Lewy bodies Ian Grant McKeith et al. · Neurology | 27 Dec 2005 | 5,092 |
| 36 | A sharper Bonferroni procedure for multiple tests of significance Yosef Hochberg · Biometrika | 1988 | 4,776 |
| 37 | Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine | 21 Mar 2018 | 4,756 |
| 38 | Terabit free-space data transmission employing orbital angular momentum multiplexing Jian Wang, Jeng-Yuan Yang, Irfan M. Fazal et al. · Nature Photonics | 22 Jun 2012 | 4,661 |
| 39 | Failure Criteria for Unidirectional Fiber Composites Zvi Hashin · Journal of Applied Mechanics | Jun 1980 | 4,592 |
| 40 | Global effects of land use on local terrestrial biodiversity Tim Newbold et al. · Nature | 31 Mar 2015 | 4,413 |
| 41 | The ATLAS Experiment at the CERN Large Hadron Collider G. Aad et al. · Journal of Instrumentation | 14 Aug 2008 | 4,271 |
| 42 | Controlling the false discovery rate in behavior genetics research Yoav Benjamini, Dan Drai, Gregory I. Elmer et al. · Behavioural Brain Research | Nov 2001 | 4,264 |
| 43 | Maxmin expected utility with non-unique prior Itzhak Gilboa, David Schmeidler · Journal of Mathematical Economics | 1989 | 4,217 |
| 44 | High resolution schemes for hyperbolic conservation laws Ami Harten · Journal of Computational Physics | Mar 1983 | 4,199 |
| 45 | International R&D spillovers David T. Coe, Elhanan Helpman · European Economic Review | May 1995 | 4,195 |
| 46 | Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet | May 2002 | 4,190 |
| 47 | Export Versus FDI with Heterogeneous Firms Elhanan Helpman, Marc J. Melitz, Stephen Yeaple · American Economic Review | Feb 2004 | 4,104 |
| 48 | Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range Tadej Battelino et al. · Diabetes Care | 8 Jun 2019 | 4,012 |
| 49 | Tensional homeostasis and the malignant phenotype Matthew J. Paszek, Nastaran Zahir, Kandice R. Johnson et al. · Cancer Cell | Sep 2005 | 4,000 |
| 50 | Gaia Early Data Release 3 A. G. A. Brown et al. · Astronomy and Astrophysics | 3 Dec 2020 | 3,978 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.